Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 1/2014

01-01-2014 | Original Article

Feasibility of [123I]-meta-iodobenzylguanidine dynamic 3-D kinetic analysis in vivo using a CZT ultrafast camera: preliminary results

Authors: Erica Tinti, Vincenzo Positano, Assuero Giorgetti, Paolo Marzullo

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 1/2014

Login to get access

Abstract

Purpose

No data are yet available in the literature concerning 3-D [123I]-meta-iodobenzylguanidine ([123I]-MIBG) kinetics in vivo. In this study we investigated the feasibility of dynamic 3-D [123I]-MIBG kinetic analysis using a CZT ultrafast camera.

Methods

The study group comprised 16 patients consecutively scheduled for [123I]-MIBG cardiac scintigraphy for clinical purpose who were studied using a CZT camera (NM530c, GE). Dynamic acquisition in list mode was simultaneously started with a bolus injection of the radiotracer (185–370 MBq) for an overall duration of 900 s. A temporal series of 3-D volumes was reconstructed from the first 150 s of dynamic acquisition with a temporal resolution of 5 s. A summed cardiac image was also reconstructed to serve as reference for blood pool (BP) and left ventricle (LV) wall identification. BP and LV volumes of interest (VOIs) were manually drawn to cover the whole heart and automatically reported on the reframed volumes. Time–activity curves (TACs) for the BP and LV were extracted by averaging the signal intensity in the respective VOI in each time frame. BP TACs were fitted to a gamma variate model while LV TACs were fitted to a bicompartmental model.

Results

TAC analysis was feasible in all patients with good interobserver reproducibility. BP TACs were well described by a gamma variate model as they represent the first pass of the tracer. The first compartment of LV TACs corresponded to contamination spillover of the LV signal from the BP signal. The LV second compartment characterized the uptake of the tracer in the myocardium quantified in terms of maximum signal intensity value (6.95 ± 2.76 counts/mm3/s2), maximum up-slope value (0.36 ± 0.15 counts/mm3/s) and normalized washout of the signal value (7.0 ± 0.6 %).

Conclusion

Using CZT technology and dynamic 3-D acquisition, analysis of [123I]-MIBG radiotracer kinetics in vivo is feasible and may provide pathophysiological information in addition to that available with standard planar and SPECT imaging.
Literature
1.
go back to reference Chirumamilla A, Travin MI. Cardiac applications of 123I-mIBG imaging. Semin Nucl Med. 2011;41:374–87.PubMedCrossRef Chirumamilla A, Travin MI. Cardiac applications of 123I-mIBG imaging. Semin Nucl Med. 2011;41:374–87.PubMedCrossRef
2.
go back to reference Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef Jacobson AF, Senior R, Cerqueira MD, Wong ND, Thomas GS, Lopez VA, et al. Myocardial iodine-123 meta-iodobenzylguanidine imaging and cardiac events in heart failure. Results of the prospective ADMIRE-HF (AdreView Myocardial Imaging for Risk Evaluation in Heart Failure) study. J Am Coll Cardiol. 2010;55:2212–21.PubMedCrossRef
3.
go back to reference Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.PubMedCrossRef Flotats A, Carrió I, Agostini D, Le Guludec D, Marcassa C, Schäfers M, et al. Proposal for standardization of 123I-metaiodobenzylguanidine (MIBG) cardiac sympathetic imaging by the EANM Cardiovascular Committee and the European Council of Nuclear Cardiology. Eur J Nucl Med Mol Imaging. 2010;37:1802–12.PubMedCrossRef
4.
go back to reference Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011;52:210–7.PubMedCrossRef Garcia EV, Faber TL, Esteves FP. Cardiac dedicated ultrafast SPECT cameras: new designs and clinical implications. J Nucl Med. 2011;52:210–7.PubMedCrossRef
5.
go back to reference Positano V, Pepe A, Santarelli MF, Scattini B, De Marchi D, Ramazzotti A, et al. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed. 2007;20:578–90.PubMedCrossRef Positano V, Pepe A, Santarelli MF, Scattini B, De Marchi D, Ramazzotti A, et al. Standardized T2* map of normal human heart in vivo to correct T2* segmental artefacts. NMR Biomed. 2007;20:578–90.PubMedCrossRef
6.
go back to reference Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. Siam J Appl Math. 1963;11:431.CrossRef Marquardt DW. An algorithm for least-squares estimation of nonlinear parameters. Siam J Appl Math. 1963;11:431.CrossRef
7.
go back to reference Blomley MJ, Dawson P. Bolus dynamics: theoretical and experimental aspects. Br J Radiol. 1997;70:351–9.PubMed Blomley MJ, Dawson P. Bolus dynamics: theoretical and experimental aspects. Br J Radiol. 1997;70:351–9.PubMed
8.
go back to reference Michaely HJ, Schoenberg SO, Oesingmann N, Ittrich C, Buhlig C, Friedrich D, et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements – feasibility study. Radiology. 2006;238:586–96.PubMedCrossRef Michaely HJ, Schoenberg SO, Oesingmann N, Ittrich C, Buhlig C, Friedrich D, et al. Renal artery stenosis: functional assessment with dynamic MR perfusion measurements – feasibility study. Radiology. 2006;238:586–96.PubMedCrossRef
9.
go back to reference Thompson HK, Starmer CF, Whalen RE, Mcintosh HD. Indicator transit time considered as a gamma variate. Circ Res. 1964;14:502–15.PubMedCrossRef Thompson HK, Starmer CF, Whalen RE, Mcintosh HD. Indicator transit time considered as a gamma variate. Circ Res. 1964;14:502–15.PubMedCrossRef
10.
go back to reference Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101.PubMedCrossRef Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging. 1997;7:91–101.PubMedCrossRef
11.
go back to reference Davenport R. The derivation of the gamma-variate relationship for tracer dilution curves. J Nucl Med. 1983;24:945–8.PubMed Davenport R. The derivation of the gamma-variate relationship for tracer dilution curves. J Nucl Med. 1983;24:945–8.PubMed
Metadata
Title
Feasibility of [123I]-meta-iodobenzylguanidine dynamic 3-D kinetic analysis in vivo using a CZT ultrafast camera: preliminary results
Authors
Erica Tinti
Vincenzo Positano
Assuero Giorgetti
Paolo Marzullo
Publication date
01-01-2014
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 1/2014
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-013-2549-x

Other articles of this Issue 1/2014

European Journal of Nuclear Medicine and Molecular Imaging 1/2014 Go to the issue